Atlas Trials

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Clinical trial NCT06640738 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06640738
Sponsor
Kaohsiung Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Uterine Fibroids (UF)
Start date
2024-10-01
Primary completion
2026-10-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.